m&a

Why we are dipping our toes back into EMs

Aviva has agreed terms with Friends Life for its £5.6bn takeover of the group, which will create the UK's largest insurance, savings, and asset management firm.

The private equity firms eyeing wrap provider Transact have withdrawn their approaches, Investment Week understands.

Clive Cowdery, the former head of Resolution and major shareholder at Friends Life, is set to walk away with £160m from the £5.6bn takeover deal announced on Friday.

L&G UK Alpha trust manager Richard Penny has set a £500m cap for the fund as it rises up the performance tables.

Software, chemicals and industrial suppliers are among the under-appreciated European stocks that can survive the worst of the slowdown, explains Swiss & Global's Can Elbi.

Healthcare will see ‘once-in-a-lifetime’ structural shift

M&G Recovery fund manager Tom Dobell has said his recent poor performance is down to stock selection rather than the size of his fund.

The UK's pharmaceutical sector dragged the FTSE deep into the red this morning after US giant AbbVie said it is reconsidering the planned takeover of Shire, casting doubts over elevated share prices.

US pharmaceutical firm AbbVie is reconsidering its proposed takeover of UK rival Shire following a US tax crackdown.